[HTML][HTML] Stereotactic body radiation therapy for non-small cell lung cancer: A review
KM Prezzano, SJ Ma, GM Hermann… - World journal of …, 2019 - ncbi.nlm.nih.gov
Stereotactic body radiation therapy (SBRT) is the treatment of choice for medically
inoperable patients with early stage non-small cell lung cancer (NSCLC). A literature search …
inoperable patients with early stage non-small cell lung cancer (NSCLC). A literature search …
Systematic review of single-fraction stereotactic body radiation therapy for early stage non-small-cell lung cancer and lung oligometastases: how to stop worrying and …
AJ Bartl, M Mahoney, MW Hennon, S Yendamuri… - Cancers, 2022 - mdpi.com
Simple Summary Adoption of single-fraction stereotactic body radiation therapy for lung
tumors has been limited among different institutions even during the coronavirus disease …
tumors has been limited among different institutions even during the coronavirus disease …
Long-term follow-up on NRG oncology RTOG 0915 (NCCTG N0927): a randomized phase 2 study comparing 2 stereotactic body radiation therapy schedules for …
GM Videtic, R Paulus, AK Singh, JY Chang… - International Journal of …, 2019 - Elsevier
Purpose To present long-term results of RTOG 0915/NCCTG N0927, a randomized lung
stereotactic body radiation therapy trial of 34 Gy in 1 fraction versus 48 Gy in 4 fractions …
stereotactic body radiation therapy trial of 34 Gy in 1 fraction versus 48 Gy in 4 fractions …
One versus three fractions of stereotactic body radiation therapy for peripheral stage I to II non-small cell lung cancer: a randomized, multi-institution, phase 2 trial
AK Singh, JA Gomez-Suescun, KL Stephans… - International Journal of …, 2019 - Elsevier
Purpose Stereotactic body radiation therapy for early stage non-small cell lung cancer is a
standard of care for medically inoperable patients. Our aim was to compare Common …
standard of care for medically inoperable patients. Our aim was to compare Common …
[HTML][HTML] Stereotactic ablative body radiotherapy (SABR) for bone only oligometastatic breast cancer: a prospective clinical trial
Background Stereotactic ablative body radiotherapy (SABR) is an emerging noninvasive
approach for the treatment of oligometastases. Limited prospective evidence is available in …
approach for the treatment of oligometastases. Limited prospective evidence is available in …
Oncologic outcomes of surgery versus sbrt for non–small-cell lung carcinoma: a systematic review and meta-analysis
MA Ijsseldijk, M Shoni, C Siegert, B Wiering… - Clinical Lung Cancer, 2021 - Elsevier
Background The optimal treatment of stage I non–small-cell lung carcinoma is subject to
debate. The aim of this study was to compare overall survival and oncologic outcomes of …
debate. The aim of this study was to compare overall survival and oncologic outcomes of …
[HTML][HTML] Comparison of stereotactic body radiotherapy and radiofrequency ablation for early-stage non-small cell lung cancer: a systematic review and meta-analysis
R Zhang, J Kang, S Ren, L Xing… - Annals of Translational …, 2022 - ncbi.nlm.nih.gov
Background Stereotactic body radiation therapy (SBRT) and radiofrequency ablation (RFA)
are recommended for patients with inoperable early-stage non-small cell lung cancer …
are recommended for patients with inoperable early-stage non-small cell lung cancer …
[HTML][HTML] Single-fraction stereotactic body radiation therapy: a paradigm during the coronavirus disease 2019 (COVID-19) pandemic and beyond?
Purpose Owing to the coronavirus disease 2019 (COVID-19) pandemic, radiation oncology
departments have adopted various strategies to deliver radiation therapy safely and …
departments have adopted various strategies to deliver radiation therapy safely and …
Association of neutrophil–lymphocyte ratio with survival in peripheral early-stage non-small cell lung cancer after stereotactic body radiation therapy
Background The role of neutrophil–lymphocyte ratio (NLR) as a predictor for survival in
single fraction SBRT-treated non-small cell lung cancer (NSCLC) patients remains unclear …
single fraction SBRT-treated non-small cell lung cancer (NSCLC) patients remains unclear …
A novel and clinically useful dynamic conformal arc (DCA)‐based VMAT planning technique for lung SBRT
Purpose Volumetric modulated arc therapy (VMAT) is gaining popularity for stereotactic
treatment of lung lesions for medically inoperable patients. Due to multiple beamlets in …
treatment of lung lesions for medically inoperable patients. Due to multiple beamlets in …